T cells genetically modified to express a peptide–MHC complex, normally involved in the induction of autoimmunity, can kill pathogenic T cells and inhibit autoimmune disease.
References
Jyothi, M., Flavell, R. & Geiger, T. Nat. Biotechnol., 1215–1220 (2002).
Kuchroo, V.K. et al. Annu. Rev. Immunol. 20, 101–123 (2002).
Vanderlugt, C.L. & Miller, S.D. Nat. Rev. Immunol. 2, 85–95 (2002).
Nicholson, L.A., Murtaza, A., Hafler, B.P., Sette, A. & Kuchroo, V.K. Proc. Natl. Acad. Sci. USA 94, 9279–9284 (1997).
Hosken, N., Shibuya, K., Heath, A., Murphy, K. & O'Garra, A. J. Exp. Med. 182, 1579–1584 (1995).
Nicholson, L.B. et al. Proc. Natl. Acad. USA 95, 264–269 (1998).
Nicholson, L., Greer, J., Sobel, R., Lees, M. & Kuchroo, V. Immunity 3, 397–405 (1995).
Munder, M. et al. J. Exp. Med. 196, 1151–1162 (2002).
Bielekova, B. et al. Nat. Med. 6, 1167–1175. (2000).
Kappos, L. et al. Nat. Med. 6, 1176–1182. (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wahren-Herlenius, M., Kuchroo, V. Killers come to the rescue. Nat Biotechnol 20, 1205–1206 (2002). https://doi.org/10.1038/nbt1202-1205
Issue Date:
DOI: https://doi.org/10.1038/nbt1202-1205
- Springer Nature America, Inc.